We provide continuous financial coverage including stock performance, earnings expectations, and broader economic indicators.
Burning Rock Biotech Limited American Depositary Shares (BNR) is trading at $17.0 as of 2026-05-01, notching a 4.68% gain on the day amid mild positive sentiment across the broader biotech sector. This analysis outlines key technical levels, recent market context, and potential scenarios for BNR in upcoming trading sessions, with a focus on observed support and resistance thresholds that have shaped recent price action. As a developer of precision oncology diagnostics and therapeutics, BNR’s pri
Which countries contribute most to Burning Rock (BNR) revenue? (Overhead Buying) 2026-05-01 - PCR Spike
BNR - Stock Analysis
3631 Comments
1085 Likes
1
Ugochi
Influential Reader
2 hours ago
Missed the notice… oof.
👍 250
Reply
2
Willimena
Trusted Reader
5 hours ago
Too late now… sigh.
👍 149
Reply
3
Vikash
Engaged Reader
1 day ago
Volume trends indicate active rotation between sectors, highlighting the importance of diversification.
👍 57
Reply
4
Okal
Loyal User
1 day ago
Oh no, should’ve seen this sooner. 😩
👍 235
Reply
5
Ferrari
Consistent User
2 days ago
Free US stock valuation multiples and PEG ratio analysis to identify reasonably priced growth companies with attractive risk-reward profiles. Our valuation framework helps you find stocks with the right balance of growth and value characteristics for your portfolio. We provide P/E analysis, PEG ratios, and relative valuation metrics for comprehensive valuation coverage. Find value in growth with our comprehensive valuation analysis and multiples tools for growth at a reasonable price strategies.
👍 207
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.